查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年羊膜穿刺針的全球市場
市場調查報告書
商品編碼
1169016

2022-2029 年羊膜穿刺針的全球市場

Global Amniocentesis Needles Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內（2022 年至 2029 年），羊膜穿刺針的全球市場規模預計將以 4.2% 的複合年增長率增長。

羊膜穿刺針在羊膜穿刺術中用於從子宮中取出羊水和細胞以進行檢查和治療。 在懷孕期間，嬰兒被羊水包圍和保護。 有關嬰兒健康的信息由羊膜穿刺術確定。

市場動態

推動全球羊膜穿刺針市場發展的主要因素是全球出生人數的增加以及公眾對唐氏綜合症和傳染病等致命遺傳病的認識。 新產品發布的增加有助於羊膜穿刺針市場的增長。

預計出生人數的增加和羊膜穿刺術的普及將推動市場增長。

越來越多地採用羊膜穿刺術診斷遺傳疾病、胎兒肺部檢測和傳染病、懷孕人數增加以及新產品發布數量的增加正在推動羊膜穿刺針市場。 出生人數的增加也推動了市場的增長。 許多醫療保健公司正在加緊研發活動以開發新產品。

羊膜穿刺針用於多種應用，包括基因檢測、胎兒輸血、胎兒肺部檢測、羊水減少程序、羊水過多治療、經皮臍帶取樣和胎兒感染診斷。 由於嬰兒遺傳性疾病的增加，這些應用正在擴大全球市場。 此外，預計主要參與者提供的技術先進的產品也將在市場增長中發揮重要作用。

與設備相關的風險和高成本預計會阻礙市場增長。

存在多種風險，例如羊水滲漏，羊水穿刺後會有少量羊水從陰道漏出。 這種情況很少見，不會影響懷孕。 針刺傷可能導致嬰兒將他們的腿或手臂放在針的路徑上並受傷。

在孕中期，如果有經驗的人在超聲波的幫助下進行羊膜穿刺術，流產的風險很小。 它可能引發尿毒症。 Rh 致敏也是嬰兒血細胞進入母親血液引起的並發症。 Rh 陰性母親被注射 Rh 免疫球蛋白，以防止母親的身體產生會損害嬰兒血細胞的 Rh 抗體。

COVID-19 影響分析

疫情正在對全球金融預期、運營和危機應對策略產生負面影響。 COVID-19 的爆發嚴重影響了醫療保健行業。 由於 COVID 病例的增加，各種研究和臨床試驗已經認真開始，羊膜穿刺針市場因 COVID 遭受了巨大損失。 世界各地正在發生各種舉措、產品發布、創新、合作和合併，推動了市場的增長。 例如，2021年4月，Medax SRL宣佈在印度實現MedOne Ultra和MedEasy的商業化。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 出生率增加
      • 孕婦糖尿病患病率增加
      • 羊膜穿刺術的流行率上升
    • 約束因素
      • 羊膜穿刺術費用高
      • 並發症或感染
      • 備選方案的可用性
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 100-150mm
  • 超過 150 毫米
  • 小於 100 毫米

第八章應用

  • 羊膜穿刺術
  • 基因檢測
  • 胎兒輸血
  • 胎兒肺活量測定
  • 羊水消化治療
  • 煩渴治療
  • 經皮臍帶取樣
  • 胎兒感染的診斷

第 9 章最終用戶

  • 醫院
  • 診斷中心
  • 專科診所
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第12章公司簡介

  • Cooper Surgical Inc.
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Cook
  • ICU Medical Inc.
  • Biopsybell
  • Becton, Dickinson and Company
  • Medline Industries LP
  • RI. MOS. Srl
  • Laboratoire CCD
  • Rocket Medical Plc
  • Medax Srl

第13章 DataM

簡介目錄
Product Code: DMMD1224

Market Overview

The global amniocentesis needles market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.2% during the forecast period (2022-2029).

The amniocentesis needles are utilized for the amniocentesis procedure in which amniotic fluid or cells are removed for testing and treatment from the uterus. The baby is surrounded and protected by amniotic fluid during the pregnancy. Information regarding the baby's health can be determined via amniocentesis.

Market Dynamics

The major factors driving the global amniocentesis needles market are an increase in the number of childbirths across the globe and awareness among the population regarding fatal genetic disorders such as down's syndrome or infections. An increase in novel product launches contributes to the growth of the amniocentesis needles market.

The increasing number of childbirths and increasing adoption of amniocentesis procedures are expected to drive the market's growth.

The rising adoption of amniocentesis procedures for genetic disorders, fetal lung testing and infection diagnosis, an increase in pregnancies, and the rising number of novel product launches drive the amniocentesis needles market. An increase in the number of childbirths is also aiding the market growth. There has been an increase in R&D activities by many healthcare companies to develop novel products.

Amniocentesis needles are used in various applications such as genetic testing, fetal blood transfusion, fetal lung testing, amnioreduction procedure, polyhydramnios treatment, percutaneous umbilical cord sampling, and fetal infection diagnosis. The market for these applications is increasing worldwide due to the increasing number of infant genetic disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches and research studies contribute to the market's growth. For instance, in January 5, 2021, Cooper Surgical, a women's healthcare solution provider, announced its acquisition of Embryo Options, a cryo-storage solutions provider. This acquisition enhances Cooper's innovative fertility product portfolio.

The risks associated with these devices and the high cost are expected to hamper the market's growth.

However, there are several risks faced by the minor population, such as leakage of amniotic fluid in which, after amniocentesis small amount of amniotic fluid starts leaking through the vagina. This is rare and doesn't affect pregnancy. Needle injury is another risk where the baby might bring its leg or arm in the path of the needle that, causes injury.

During the second trimester, there is a little risk of miscarriage in the amniocentesis procedure if done by an experienced person with the help of ultrasound. It can trigger a urine infection. Rh sensitization is also a complication when a baby's blood cells enter the mother's bloodstream. Rh-negative mother is given Rh immunoglobulin injection to prevent the mother's body from making Rh antibodies that can cause damage to the blood cells of the baby.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The amniocentesis needles market has experienced huge losses due to COVID, as various research and clinical trials started in full swing due to the increasing cases of COVID. Various initiatives, product launches, innovations, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Apr 2021, Medax SRL announced the commercialization of MedOne Ultra and MedEasy in India.

Segment Analysis

The amniocentesis segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The amniocentesis segment is the largest market shareholder due to its high demand, increasing childbirth and rising adoption of amniocentesis procedures.

A prenatal test named amniocentesis is done for genetic disorders diagnosis. Genetic disorders, including spina bifida and down syndrome and other fetus health issues. Amniocentesis needles are used for amniotic fluid removal in a small amount from the uterus. The lab then tests the amniotic fluid sample for various genetic or chromosomal conditions. This procedure is done during the second or third trimester of pregnancy.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, MRD SRL's Amnio needle is a novel stainless steel cannula needle that is disposable and is used for amniotic fluid transabdominal sampling for prenatal diagnosis of the fetus, such as genetic disorders known as amniocentesis. This needle has an echogenic marker that supports correct needle placement in ultrasound guidance. Adjustable stoppers and centimeter markings help to determine the insertion depth.

Geographical Analysis

North America holds the largest market share in the global amniocentesis needles market.

North America dominates the global amniocentesis needles market, primarily due to its large population combined with excellent medical infrastructure and the rising number of childbirth and pregnancies. According to National Centre for Health, in 2022, cancer was the second leading cause of mortality worldwide, with around 1,918,030 new cases registered 2022. Cancer was responsible for 609,360 deaths all over the world. Moreover, as per WHO, the number of new cases is expected to rise by around 70% by 2030.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of applications of amniocentesis needles in amniocentesis procedures and prenatal diagnostics, such as genetic disorders and fatal infections, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the amniocentesis needles market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Jan 6, 2022, ICU Medical Inc., announced it had completely acquired Smiths Medical from the Smith's Group. Smith's Medical business such as syringes, vital care and vascular access products, and ambulatory infusion devices.

Competitive Landscape

The amniocentesis needles market is moderately competitive with local and global companies' presence. Cooper Surgical Inc., Cook, ICU Medical Inc., Biopsybell, Becton, Dickinson and Company, Medline Industries LP, RI. MOS. Srl, Laboratoire CCD, Rocket Medical Plc, Medax Srl and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Dec 17, 2021, Cooper Companies announced its completion of an acquisition agreement with Generate Life Sciences, a donor egg and sperm provider for fertility treatment and stem cell storage of newborns (cord tissue and blood).

Cooper Surgical Inc.

Overview: Cooper Surgical is a medical device company that focuses on women's and babies' health advancements with its wide products and services portfolio on fertility and genomics, and medical devices. It was established in 1990 and is headquartered in Connecticut, United States.

Product Portfolio:

Wallace Amniocentesis Needles: Wallace is an amniocentesis single-use needle that is provided in sterile packs for the sampling of amniotic fluid. The tip of the needle contains spiral engraving that offers clear visibility.

The global amniocentesis needles market report would provide access to approx. 45 + market data tables, 40 + figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Childbirth
      • 4.1.1.2. Prevalence of Diabetes in the Pregnant Woman
      • 4.1.1.3. Increasing Adoption of Amniocentesis Procedures.
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost of Amniocentesis Procedures
      • 4.1.2.2. Complications or Infections
      • 4.1.2.3. Availability of Substitutes
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. 100-150mm *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Larger than 150mm
  • 7.4. Smaller than 100mm

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Amniocentesis *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Genetic testing
  • 8.4. Fetal Blood Transfusion
  • 8.5. Fetal Lung Testing
  • 8.6. Amnioreduction Procedure
  • 8.7. Polyhydramnios Treatment
  • 8.8. Percutaneous Umbilical Cord Sampling
  • 8.9. Fetal Infection Diagnosis

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Diagnostic Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Cooper Surgical Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cook
  • 12.3. ICU Medical Inc.
  • 12.4. Biopsybell
  • 12.5. Becton, Dickinson and Company
  • 12.6. Medline Industries LP
  • 12.7. RI. MOS. Srl
  • 12.8. Laboratoire CCD
  • 12.9. Rocket Medical Plc
  • 12.10. Medax Srl

LIST NOT EXHAUSTIVE

13. Global Amniocentesis Needles Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and End-User
  • 13.3. Contact Us